Nhgri: service: AAV9 vector DNA analysis: non-severable
Active Purchase Order Awarded Last action
- Contract number
- 75N98027P00031
- Awardee
-
Charles River Laboratories Montréal ULC UEI RJ2LHK6GS9S4
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $302,714
Award facts
- Opportunity
-
- Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR Pre-Solicitation · 75N98027Q00015 · Posted Oct 15, 2026
- Contract value 100% obligated
- $302,714.00 Current and potential, with all options
- Completion date 1% complete
- Current and potential, with all options
- Funding agency
- National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from SAM.gov/FPDS.
About this award
The National Human Genome Research Institute awarded a $302,714 firm-fixed-price purchase order to Charles River Laboratories Montréal ULC on October 26, 2026, for AAV9 vector DNA analysis services supporting preclinical research. Work is performed at 2323 Riverside Drive, Ottawa, Ontario, Canada. The purchase order covers mouse tissue histology processing and histopathology staining, along with AAV9 antibody screening of mouse serum samples in support of a preclinical trial testing efficacy and safety of therapeutic adenine DNA base editing administered via Adeno-Associated Virus 9 in a humanized mouse model of Hutchinson Gilford Progeria Syndrome. Services support an FDA Investigational New Drug application for SamPro-2 intended for Phase 1/2 clinical trials in HGPS patients. All work incorporates Good Laboratory Practice-compliant documentation. Performance concludes October 25, 2027. The requirement originated from a pre-solicitation notice posted October 15, 2026, under FAR Part 6.302-1 single-source justification, with capability statement deadline October 21, 2026.
Quick answers
Who was awarded contract 75N98027P00031?
75N98027P00031 was awarded to Charles River Laboratories Montréal ULC by Office of Logisitics and Acquisition Operations (National Institutes of Health) on October 26, 2026.
How much is contract 75N98027P00031 worth?
The government has obligated $302,714 on 75N98027P00031.
Which agency awarded contract 75N98027P00031?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98027P00031, with funding from National Human Genome Research Institute (National Institutes of Health).
Was contract 75N98027P00031 competed?
The extent of competition for 75N98027P00031 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award